Dr. Reddy's Laboratories Ltd. ADR buy HSBC Holdings plc
Start price
05.06.25
/
50%
€13.80
Target price
05.06.26
€14.80
Performance (%)
-15.94%
Price
12.12.25
€11.70
Summary
This prediction is currently active. The prediction for Dr. Reddy's Laboratories Ltd. ADR disappoints with a performance of -15.94%. This prediction currently runs until 05.06.26. The prediction end date can be changed by HSBC_Holdings_plc at any time. HSBC_Holdings_plc has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | -3.306% | -3.306% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by HSBC_Holdings_plc for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Ratings data for RDY provided by MarketBeat